Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Athersys Inc (NASDAQ:ATHX)

1.99
Delayed Data
As of Oct 20
 +0.15 / +8.15%
Today’s Change
1.02
Today|||52-Week Range
2.63
+30.07%
Year-to-Date

Today’s Trading

Previous close1.84
Today’s open1.86
Day’s range1.82 - 2.01
Volume1,507,013
Average volume (3 months)1,043,204
Market cap$226.7M
Dividend yield--
Data as of 3:59pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)+10.00%
Earnings growth (this year)-31.48%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+45.19%
P/E ratioNM
Price/Sales7.47
Price/Book15.42

Competitors

 Today’s
change
Today’s
% change
NYMXNymox Pharmaceutical...+0.01+0.26%
OBSVObseva SA+0.27+2.57%
NLNKNewLink Genetics Cor...-0.21-2.04%
MNOVMediciNova Inc-0.05-0.81%
Data as of 3:59pm ET, 10/20/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$17.3M
Annual profit (last year)-$15.3M
Net profit margin-88.41%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Gil van Bokkelen
President, Chief Operating Officer &
Secretary
William B. J. Lehmann
Corporate headquarters
Cleveland, Ohio

Forecasts